Interim report, foreign filer
Open the filing on sec.gov
Optimi Health Corp. (OPTH)
Nasdaq: OPTH · Pharmaceutical Preparations · filing with the SEC since 2024
The companyas filed
Revenuen/a
Net incomen/a
Earnings per sharen/a
Operating cash flown/a
Cashn/a
Debtn/a
Shareholders’ equityn/a
Shares, dilutedn/a
Return on equityn/a
The recordfrom its filings
Filings in 202642
Newest filingOct 26 · 6-K
Annual reportn/a
Quarterly reportn/a
Next report due10-Q by Feb 14
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted0
Filer categoryn/a
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
The record holds no annual figures yet.
As filed, in USD. Nothing here is a forecast.
News
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Large holder update, amended
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Interim report, foreign filer
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.